Deverra Therapeutics Inc., a clinical-stage company in Seattle, has entered into a manufacturing service agreement with the Cleveland Cell Therapy Incubator, a subsidiary of the nonprofit Cleveland Cord Blood Center, to make clinical-grade materials.